Home > News > An autonomous anti-cancer drug
March 16th, 2007
An autonomous anti-cancer drug
Abstract:
As you probably know, researchers have been working for a while to find more efficient ways to deliver anti-cancer drugs directly to their targets. But instead of finding a new drug carrier, why not focusing on a drug that knows its path to the target and which delivers itself to the tumor? This is what University at Buffalo (UB) scientists have done by developing a solution in which the delivery system is the drug itself by using nanocrystals of a hydrophobic drug. But this research work needs to be confirmed before this drug can be approved by the medical regulators. And it will take time…
Source:
zdnet.com
Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
Discoveries
Chemical reactions can scramble quantum information as well as black holes April 5th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Utilizing palladium for addressing contact issues of buried oxide thin film transistors April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Simulating magnetization in a Heisenberg quantum spin chain April 5th, 2024
Discovery points path to flash-like memory for storing qubits: Rice find could hasten development of nonvolatile quantum memory April 5th, 2024
Human Interest/Art
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
JEOL Announces 2020 Microscopy Image Grand Prize Winners January 7th, 2021
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||